FDA Accepts New Drug Application for Investigational Insomnia Drug
A New Drug Application for suvorexant, Merck’s investigational insomnia medicine, has been accepted for standard review by the US Food and Drug Administration.
Read MoreA New Drug Application for suvorexant, Merck’s investigational insomnia medicine, has been accepted for standard review by the US Food and Drug Administration.
Read MoreExtending sleep duration may help to reduce overeating.
Read MoreA novel brain mechanism mediating the inhibition of the critical breathing muscles during REM sleep has been identified for the first time in a new study, offering the possibility of a new treatment target for sleep-related breathing problems.
Read MoreForeign students increasingly are seeking out US-based polysomnography training programs to get the training they need to build their own skills and build the sleep field in their home countries.
Read MoreMichael Coppola, MD, FCCP, believes portable monitoring will become the dominant testing modality through supporting research.
Read More